Key factors predict gallbladder cancer on routine cholecystectomyFebruary 15, 2023Genitourinary CancerOncology
New cancer data spark outcry from patient advocatesJanuary 30, 2023OncologyGenitourinary CancerProstate Cancer
People with cancer should be wary of taking dietary supplementsJanuary 23, 2023Lung CancerOncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid Cancers
Oncologists may be too quick to refer patients to palliative careJanuary 18, 2023OncologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
‘Low-value’ prostate cancer screening prevalent in primary careJanuary 9, 2023Genitourinary CancerOncologyProstate Cancer
Atezolizumab (Tecentriq) bladder cancer indication withdrawn in United StatesDecember 1, 2022Genitourinary CancerOncology
Is early-onset cancer an emerging global epidemic?October 5, 2022Breast CancerHead & Neck/Thyroid CancersGenitourinary CancerOncology
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerColon and RectalHead & Neck/Thyroid CancersMelanomaGenitourinary Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022OncologyMixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerOncologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Concurrent Romiplostim With FOLFIRINOX for Secondary Prevention of Thrombocytopenia in a Patient With Myelodysplastic Syndrome and Pancreatic AdenocarcinomaSeptember 9, 2022Genitourinary CancerOncology
The ‘great dynamism’ of radiation oncologyAugust 18, 2022Lung CancerMixed TopicsBreast CancerHead & Neck/Thyroid CancersGenitourinary Cancer
The Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single CenterAugust 12, 2022Genitourinary CancerOncology
